G. Ndrepepa

发表

Electrophysiologic characteristics of paroxysmal and chronic atrial fibrillation in human right atrium.

Michael A. E. Schneider, C. Schmitt, A. Schömig, 2001, Journal of the American College of Cardiology.

Activation Time Determination by High‐Resolution Unipolar and Bipolar Extracellular Electrograms in the Canine Heart

G. Ndrepepa, E. Caref, H. Yin, 1995, Journal of cardiovascular electrophysiology.

Clinical experience with a novel multielectrode basket catheter in right atrial tachycardias.

Michael A. E. Schneider, C. Schmitt, A. Schömig, 1999, Circulation.

Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation: A Randomized Comparison Between 2 Current Ablation Strategies

Claus Schmitt, Isabel Deisenhofer, Albert Schömig, 2005, Circulation.

Antithrombotic treatment in primary percutaneous coronary intervention

A. Kastrati, G. Ndrepepa, F. Voll, 2021, Expert review of cardiovascular therapy.

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.

W. Rottbauer, M. Fischer, H. Schunkert, 2019, The New England journal of medicine.

Gamma-glutamyl transferase and cardiovascular disease.

A. Kastrati, G. Ndrepepa, 2016, Annals of translational medicine.

Early Resolution of ST-Segment Elevation Correlates With Myocardial Salvage Assessed by Tc-99m Sestamibi Scintigraphy in Patients With Acute Myocardial Infarction After Mechanical or Thrombolytic Reperfusion Therapy

M. Schwaiger, A. Kastrati, J. Mehilli, 2002, Circulation.

Research update for articles published in EJCI in 2015

N. Goswami, A. Roessler, M. Qorbani, 2017, European journal of clinical investigation.

Do Current Dual Chamber Cardioverter Defibrillators Have Advantages Over Conventional Single Chamber Cardioverter Defibrillators in Reducing Inappropriate Therapies? A Randomized, Prospective Study

C. Schmitt, B. Zrenner, G. Ndrepepa, 2001, Journal of cardiovascular electrophysiology.

Age-Dependent Effect of Abciximab in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions

A. Kastrati, J. Mehilli, J. Dirschinger, 2006, Circulation.

Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction.

A. Kastrati, A. Schömig, G. Ndrepepa, 2006, European heart journal.

Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial

S. Nekolla, M. Schwaiger, A. Kastrati, 2005 .

Ability of mechanical reperfusion to salvage myocardium in patients with acute myocardial infarction presenting beyond 12 hours after onset of symptoms.

M. Schwaiger, A. Kastrati, J. Mehilli, 2006, American heart journal.

Delineation of Intra‐Atrial Reentrant Tachycardia Circuits After Mustard Operation for Transposition of the Great Arteries Using Biatrial Electroanatomic Mapping and Entrainment Mapping

C. Schmitt, A. Schömig, B. Zrenner, 2003, Journal of cardiovascular electrophysiology.

Acute and Long‐Term Results of Slow Pathway Ablation in Patients with Atrioventricular Nodal Reentrant Tachycardia—An Analysis of the Predictive Factors for Arrhythmia Recurrence

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2005, Pacing and clinical electrophysiology : PACE.

Serum potassium levels on admission and infarct size in patients with acute myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2009, Clinica chimica acta; international journal of clinical chemistry.

Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI—Design and Rationale of the Randomized ISAR-PLASTER Trial

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Thrombosis and Haemostasis.

Primary PCI, Late Presenting STEMI, and the Limits of Time.

A. Kastrati, G. Ndrepepa, J. Coughlan, 2021, Journal of the American College of Cardiology.

Reperfusion injury in ST-segment elevation myocardial infarction: the final frontier.

A. Kastrati, G. Ndrepepa, R. Colleran, 2017, Coronary artery disease.

Improving myocardial injury, infarct size, and myocardial salvage in the era of primary PCI for STEMI

G. Ndrepepa, 2015, Coronary artery disease.

Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction.

M. Schwaiger, A. Kastrati, J. Mehilli, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis

S. Nekolla, M. Schwaiger, A. Kastrati, 2003, Circulation.

Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials.

A. Kastrati, A. Schömig, G. Ndrepepa, 2012 .

Antithrombotic therapy with or without aspirin after percutaneous coronary intervention or acute coronary syndrome in patients taking oral anticoagulation: A meta-analysis and network analysis of randomized controlled trials.

A. Kastrati, G. Ndrepepa, K. Mayer, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Bleeding complications in patients undergoing percutaneous coronary interventions: current status and perspective.

A. Kastrati, G. Ndrepepa, 2014, Coronary artery disease.

Impact of perfusion restoration at epicardial and tissue levels on markers of myocardial necrosis and clinical outcome of patients with acute myocardial infarction.

A. Kastrati, J. Mehilli, M. Seyfarth, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Predictive Factors and Impact of No Reflow After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Circulation. Cardiovascular interventions.

Complete revascularization for patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: a meta-analysis of randomized trials

P. Ibrahimi, F. Jashari, Gani Bajraktari, 2018, Coronary artery disease.

Comparison of drug-eluting balloon versus drug-eluting stent treatment of drug-eluting stent in-stent restenosis: A meta-analysis of available evidence.

P. Ibrahimi, F. Jashari, Gani Bajraktari, 2016, International journal of cardiology.

Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials

H. Schunkert, A. Kastrati, G. Ndrepepa, 2015, Clinical Research in Cardiology.

Activated clotting time during percutaneous coronary intervention: a test for all seasons or a mind tranquilizer?

A. Kastrati, G. Ndrepepa, 2015, Circulation. Cardiovascular interventions.

Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.

A. Kastrati, J. Mehilli, F. Neumann, 2008, Journal of the American College of Cardiology.

Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality.

A. Kastrati, J. Mehilli, F. Neumann, 2010, The American journal of cardiology.

Prognostic Value of High-sensitivity Troponin T After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, Revista espanola de cardiologia.

Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis

H. Schunkert, M. Joner, A. Kastrati, 2022, Clinical Research in Cardiology.

Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial.

H. Schunkert, A. Kastrati, A. Hapfelmeier, 2021, JAMA cardiology.

Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)

R. de Caterina, H. Bøtker, A. Jaffe, 2021, European heart journal.

Cardiac procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data

A. Jaffe, J. Mehilli, K. Thygesen, 2020, European Heart Journal.

Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: looking for the reasons.

A. Kastrati, A. Schömig, G. Ndrepepa, 2007, JAMA.

Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients.

A. Kastrati, G. Ndrepepa, P. D. de Groot, 2013, Thrombosis research.

Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations.

A. Kastrati, A. Schömig, G. Ndrepepa, 2004, Atherosclerosis.

Relation of Hypocholesterolemia With Diabetes Mellitus in Patients With Coronary Artery Disease.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2020, The American journal of cardiology.

Hypocholesterolaemia and mortality in patients with coronary artery disease

A. Kastrati, G. Ndrepepa, S. Holdenrieder, 2019, European journal of clinical investigation.

Mechanical strategies to enhance myocardial salvage during primary percutaneous coronary intervention in patients with STEMI.

A. Kastrati, G. Ndrepepa, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis: The REPAIR Cooperation A Meta-Analysis of Individual Participant Data From 3 Randomized Trials

M. Fusaro, G. Ndrepepa, I. Ott, 2018, Circulation. Cardiovascular interventions.

Need for critical reappraisal of intra-aortic balloon counterpulsation.

A. Kastrati, G. Ndrepepa, 2011, JAMA.

C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention.

A. Kastrati, G. Ndrepepa, S. Braun, 2013, Cardiovascular revascularization medicine : including molecular interventions.

Use of Atrial Defibrillators to Convert Atrial Fibrillation at Home:

C. Schmitt, G. Ndrepepa, 2003, Journal of cardiovascular electrophysiology.

U-shaped association of central pulse pressure with long-term prognosis after ST-segment elevation myocardial infarction

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Heart and Vessels.

Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.

Samin K. Sharma, A. Jaffe, S. Ooi, 2020, European heart journal.

Predictors of mortality in medically treated patients with congestive heart failure of nonrheumatic etiology and reduced systolic function.

Gani Bajraktari, G. Ndrepepa, S. Elezi, 2009, European journal of internal medicine.

Accuracy of N-Terminal Probrain Natriuretic Peptide to Predict Mortality or Detect Acute Ischemia in Patients with Coronary Artery Disease

A. Kastrati, J. Mehilli, A. Schömig, 2007, Cardiology.

Prognostic value of haemoglobin drop in patients with acute coronary syndromes

H. Schunkert, M. Joner, A. Kastrati, 2021, European journal of clinical investigation.

Bivalirudin Versus Heparin Plus a Glycoprotein IIb/IIIa Inhibitor in Patients With Non–ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: Pooled Analysis from the ACUITY and ISAR-REACT 4 Trials

G. Stone, A. Kastrati, J. Mehilli, 2012, Circulation. Cardiovascular interventions.

Cangrelor - a champion lost in translation?

A. Kastrati, G. Ndrepepa, 2009, The New England journal of medicine.

Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, Clinical Research in Cardiology.

Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials

S. Bhattacharya, A. Kastrati, J. Mehilli, 2008, Heart.

Cardiogenic Shock: How Long Does the Storm Last?

A. Kastrati, G. Ndrepepa, R. Colleran, 2016, Journal of the American College of Cardiology.

Intravenous β-blockers in primary percutaneous coronary intervention: new hope for an old therapy.

A. Kastrati, G. Ndrepepa, 2013, Circulation.

Mechanical Reperfusion More Than 12 Hours After Acute Myocardial Infarction—Reply

A. Kastrati, A. Schömig, G. Ndrepepa, 2005 .

High-density lipoprotein: a double-edged sword in cardiovascular physiology and pathophysiology

G. Ndrepepa, 2021, Journal of Laboratory and Precision Medicine.

Thoracic radiotherapy in patients with lymphoma and restenosis after coronary stent placement

A. Kastrati, J. Mehilli, J. Pache, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Sex differences in the outcome after percutaneous coronary intervention - A propensity matching analysis.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Prognostic value of gamma-glutamyl transferase in patients with diabetes mellitus and coronary artery disease.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, Clinical biochemistry.

Intravenous Beta Blockers in Primary PCI: New Hope for an Old Therapy

A. Kastrati, G. Ndrepepa, 2013 .

Aspartate aminotransferase and mortality in patients with ischemic heart disease.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction.

S. Nekolla, M. Schwaiger, A. Kastrati, 2005, Journal of the American College of Cardiology.

Coronary artery thrombus in patients with ST-segment elevation myocardial infarction: bad to have it, bad to remove it and a case for glycoprotein IIb/IIIa inhibitors?

G. Ndrepepa, 2016, Coronary artery disease.

Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

H. Schunkert, M. Joner, A. Kastrati, 2020, Circulation.

Outcome after out-of-hospital cardiac arrest in a physician-staffed emergency medical system according to the Utstein style.

C. Schmitt, A. Schömig, G. Ndrepepa, 2007, American heart journal.

Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms.

A. Kastrati, J. Mehilli, A. Schömig, 2009, JAMA.

Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials.

H. Schunkert, P. Serruys, J. Wykrzykowska, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation

A. Kastrati, J. Mehilli, A. Schömig, 2008, Journal of internal medicine.

Inverse association of alanine aminotransferase within normal range with prognosis in patients with coronary artery disease.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Clinica chimica acta; international journal of clinical chemistry.

Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Five-year outcome of patients with acute myocardial infarction enrolled in a randomised trial assessing the value of abciximab during coronary artery stenting.

A. Kastrati, J. Mehilli, F. Neumann, 2004, European heart journal.

Glycoprotein IIb/IIIa Receptor Inhibition with Abciximab during Percutaneous Coronary Interventions Increases the Risk of Bleeding in Patients with Impaired Renal Function

A. Kastrati, J. Mehilli, A. Schömig, 2008 .

One-Year Ischemic and Bleeding Events According to Renal Function in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Third-Generation Antiplatelet Drugs.

A. Kastrati, G. Ndrepepa, K. Mayer, 2022, The American journal of cardiology.

Statin pretreatment and presentation patterns in patients with coronary artery disease.

A. Kastrati, A. Schömig, G. Ndrepepa, 2013, Cardiology journal.

Glycosylated hemoglobin at early follow-up and outcome in diabetic patients with ST-segment elevation myocardial infarction.

G. Ndrepepa, 2015, Coronary artery disease.

Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2007, American heart journal.

Alkaline phosphatase and cardiovascular disease

G. Ndrepepa, 2017 .

N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.

A. Kastrati, J. Mehilli, A. Schömig, 2006, The American journal of medicine.

Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction.

A. Kastrati, J. Mehilli, A. Schömig, 2005, The American journal of cardiology.

Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes.

A. Kastrati, J. Mehilli, M. Seyfarth, 2008, Journal of the American College of Cardiology.

A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, American heart journal.

One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2010, Clinical Research in Cardiology.

Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial

A. Kastrati, J. Mehilli, F. Dotzer, 2011, Clinical Research in Cardiology.

Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes

H. Schunkert, A. Kastrati, F. Neumann, 2020, Annals of Internal Medicine.

Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2011, Clinical Research in Cardiology.

Reentrant arrhythmias in the subacute infarction period. The proarrhythmic effect of flecainide acetate on functional reentrant circuits.

G. Ndrepepa, M. Avitable, E. Caref, 1995, Circulation.

Circumferential mapping and electric isolation of pulmonary veins in patients with atrial fibrillation.

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2003, The American journal of cardiology.

Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease

A. Kastrati, A. Schömig, G. Ndrepepa, 2011, Clinical Research in Cardiology.

Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes.

H. Schunkert, M. Joner, A. Kastrati, 2021, Revista espanola de cardiologia.

Minimising bleeding during percutaneous coronary intervention

A. Kastrati, G. Ndrepepa, 2015, BMJ : British Medical Journal.

Reply: Baseline or Post-Procedural High-Sensitivity Troponin? Probably Both.

A. Kastrati, G. Ndrepepa, R. Colleran, 2017, Journal of the American College of Cardiology.

N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis.

S. Nekolla, M. Schwaiger, A. Kastrati, 2006, The American journal of cardiology.

Myocardial Salvage after Reduced-Dose Thrombolysis Combined with Glycoprotein IIb/IIIa Blockade Versus Thrombolysis Alone in Patients with Acute Myocardial Infarction

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, Journal of Thrombosis and Thrombolysis.

Research update for articles published in EJCI in 2011

Yen-Hung Lin, N. Goswami, A. Roessler, 2013 .

Alkaline Phosphatase and Prognosis in Patients with Diabetes Mellitus and Ischemic Heart Disease.

A. Kastrati, G. Ndrepepa, S. Kufner, 2022, Clinica chimica acta; international journal of clinical chemistry.

Creatine kinase and bleeding in patients with acute coronary syndromes

A. Kastrati, G. Ndrepepa, S. Holdenrieder, 2021, European journal of clinical investigation.

Relation of Ratio of Left Ventricular Ejection Fraction to Left Ventricular End-Diastolic Pressure to Long-Term Prognosis After ST-Segment Elevation Acute Myocardial Infarction.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, The American journal of cardiology.

Association of shock index with short-term and long-term prognosis after ST-segment elevation myocardial infarction.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Coronary artery disease.

Markers of Reperfusion and Long-Term (8-Year) Prognosis after Primary Percutaneous Coronary Intervention.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2018, The American journal of cardiology.

Comparative prognostic value of postprocedural creatine kinase myocardial band and high‐sensitivity troponin T in patients with non‐ST‐segment elevation myocardial infarction undergoing percutaneous coronary intervention

H. Schunkert, A. Kastrati, G. Ndrepepa, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Gamma-glutamyl transferase and atrial fibrillation in patients with coronary artery disease.

A. Kastrati, G. Ndrepepa, R. Colleran, 2017, Clinica chimica acta; international journal of clinical chemistry.

ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2012, Cardiology journal.

High-sensitivity troponin T level and angiographic severity of coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2011, The American journal of cardiology.

Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, Clinical Research in Cardiology.

Research update for articles published in EJCI in 2008

J. Martínez, J. Carrero, A. Kastrati, 2010 .

Drug-eluting Stents in Diabetic Patients

J. Mehilli, G. Ndrepepa, 2006 .

Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial

H. Schunkert, A. Kastrati, F. Neumann, 2021, Journal of atherosclerosis and thrombosis.

Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes.

Gani Bajraktari, G. Ndrepepa, S. Elezi, 2006, International journal of cardiology.

Increased bleeding risk during percutaneous coronary interventions by arterial hypertension

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2005, Clinica chimica acta; international journal of clinical chemistry.

Circulating homocysteine levels in patients with type 2 diabetes mellitus.

A. Kastrati, J. Mehilli, A. Schömig, 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Response from the authors to: The value of elevated high-sensitivity troponin T

A. Kastrati, G. Ndrepepa, 2011 .

Myocardial perfusion grade, myocardial salvage indices and long-term mortality in patients with acute myocardial infarction and full restoration of epicardial blood flow after primary percutaneous coronary intervention.

A. Kastrati, J. Mehilli, A. Schömig, 2010, Revista espanola de cardiologia.

Tolvaptan in the very elderly with acute decompensated heart failure-a therapeutic option worth of consideration

G. Ndrepepa, 2017, Anatolian journal of cardiology.

Atherosclerosis & ischaemic heart disease: Here to stay or gone tomorrow

G. Ndrepepa, 2017, The Indian journal of medical research.

Research update for articles published in EJCI in 2013

R. Abbate, B. Miazgowski, T. Miazgowski, 2015, European journal of clinical investigation.

Area under ROC curve, sensitivity, specificity of N-terminal probrain natriuretic peptide in predicting mortality in various subsets of patients with ischemic heart disease

A. Kastrati, A. Schömig, G. Ndrepepa, 2007, Clinical Research in Cardiology.

Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, The American journal of cardiology.

Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials

A. Kastrati, J. Mehilli, A. Schömig, 2018 .

Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes

A. Kastrati, G. Ndrepepa, I. Bernlochner, 2021, Clinical Research in Cardiology.

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention

H. Schunkert, M. Joner, A. Kastrati, 2021, Circulation. Cardiovascular interventions.

Corrigendum to: Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data.

Samin K. Sharma, A. Jaffe, S. Ooi, 2021, European heart journal.

Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial

H. Schunkert, M. Joner, A. Kastrati, 2022, Clinical Research in Cardiology.

Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis.

A. Kastrati, J. Mehilli, J. Hausleiter, 2009, JACC. Cardiovascular interventions.

A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction.

M. Schwaiger, A. Kastrati, J. Mehilli, 2004, Journal of the American College of Cardiology.

Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention.

A. Kastrati, J. Mehilli, A. Schömig, 2009, Clinical science.

Relationship of left ventricular end‐diastolic pressure with extent of myocardial ischemia, myocardial salvage and long‐term outcome in patients with ST‐segment elevation myocardial infarction

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease.

A. Kastrati, G. Ndrepepa, R. Colleran, 2018, Clinica chimica acta; international journal of clinical chemistry.

Storms of ventricular tachyarrhythmias associated with primary hyperparathyroidism in a patient with dilated cardiomyopathy.

C. Schmitt, G. Ndrepepa, G. Lehmann, 2003, International journal of cardiology.

Association of In‐Hospital Hemoglobin Drop With Decreased Myocardial Salvage and Increased Long‐Term Mortality in Patients With Acute ST‐Segment–Elevation Myocardial Infarction

H. Schunkert, A. Kastrati, G. Ndrepepa, 2022, Journal of the American Heart Association.

Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis

H. Schunkert, M. Joner, A. Kastrati, 2022, Clinical Research in Cardiology.

Distribution of angiographic measures of restenosis after drug-eluting stent implantation

A. Kastrati, J. Mehilli, A. Schömig, 2009, Heart.

Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2005, American heart journal.

Is diabetes the achilles' heel of limus-eluting stents?

A. Kastrati, G. Ndrepepa, S. Massberg, 2011, Circulation.

Paclitaxel-Coated Versus Uncoated Balloon Angioplasty Reduces Target Lesion Revascularization in Patients With Femoropopliteal Arterial Disease: A Meta-Analysis of Randomized Trials

A. Kastrati, G. Ndrepepa, I. Ott, 2012, Circulation. Cardiovascular interventions.

Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

M. Hadamitzky, A. Kastrati, J. Mehilli, 2012, Circulation.

A. Kastrati, J. Mehilli, F. Neumann, 2013, American heart journal.

Response to Letter Regarding Article, “Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention”

M. Hadamitzky, A. Kastrati, J. Mehilli, 2012 .

Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease

M. Hadamitzky, A. Kastrati, J. Pache, 2012, Clinical Research in Cardiology.

Epicardial adipose tissue: An anatomic component of obesity & metabolic syndrome in close proximity to myocardium & coronary arteries

G. Ndrepepa, 2020, The Indian journal of medical research.

More deserved focus on diabetic patients.

A. Kastrati, G. Ndrepepa, L. King, 2011, Circulation. Cardiovascular interventions.

Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis.

H. Schunkert, M. Joner, A. Kastrati, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Creatine kinase myocardial band - a biomarker to assess prognostically relevant periprocedural myocardial infarction.

A. Kastrati, G. Ndrepepa, 2018, International journal of cardiology.

Prognostic value of alkaline phosphatase in patients with acute coronary syndromes.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2017, Clinical biochemistry.

Research update for articles published in EJCI in 2017

N. Goswami, G. Ndrepepa, C. Schernthaner, 2019, European journal of clinical investigation.

Bioresorbable vascular scaffold failure - Post factum research to look for the reasons.

G. Ndrepepa, 2018, International journal of cardiology.

Activation Patterns in the Left Atrium During Counterclockwise and Clockwise Atrial Flutter

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2001, Cardiovascular Electrophysiology.

Block of the Lower Interatrial Connections: Insight into the Sources of Electrocardiographic Diversities in Common Type Atrial Flutter

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2000, Pacing and clinical electrophysiology : PACE.

Dissociation Between Coronary Sinus and Left Atrial Conduction in Patients with Atrial Fibrillation and Flutter

Michael A. E. Schneider, C. Schmitt, A. Schömig, 2001, Journal of cardiovascular electrophysiology.

Influence of High‐Pass Filtering on Noncontact Mapping and Ablation of Atrial Tachycardias

Michael A. E. Schneider, C. Schmitt, A. Schömig, 2004, Pacing and clinical electrophysiology : PACE.

Acute Coronary Syndromes ender and Myocardial Salvage After eperfusion Treatment in Acute Myocardial Infarction

S. Nekolla, M. Schwaiger, A. Kastrati, 2016 .

Iron status and clinical outcome in patients with coronary artery disease after coronary stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Circulation: Cardiovascular Interventions

H. Schunkert, M. Joner, A. Kastrati, 2022 .

A comparison of gamma-glutamyl transferase and alkaline phosphatase as prognostic markers in patients with coronary heart disease.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Diagnosis and management of intramyocardial hematoma after coronary artery perforation: case studies of the Deutsches Herzzentrum München.

A. Kastrati, G. Ndrepepa, S. Kufner, 2016, Coronary artery disease.

The only better alternative to rescue percutaneous coronary intervention is primary percutaneous coronary intervention.

A. Kastrati, A. Schömig, G. Ndrepepa, 2009, Journal of the American College of Cardiology.

Alkaline phosphatase and prognosis in patients with coronary artery disease

H. Schunkert, A. Kastrati, G. Ndrepepa, 2017, European journal of clinical investigation.

Elevated fibrinogen and the risk of contrast-induced acute kidney injury during percutaneous coronary interventions.

G. Ndrepepa, 2016, Coronary artery disease.

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

G. Ndrepepa, A. Lonardo, 2022, Metabolism and Target Organ Damage.

Rebuttal: Comparative prognostic value of postprocedural creatine kinase myocardial band and high‐sensitivity troponin T in patients with non‐ST‐segment elevation myocardial infarction undergoing percutaneous coronary intervention

A. Kastrati, G. Ndrepepa, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Gamma-glutamyl transferase and prognosis in patients with coronary artery disease.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, Clinica chimica acta; international journal of clinical chemistry.

Deferred vs Immediate Stenting in Primary Percutaneous Coronary Intervention: A Collaborative Meta-analysis of Randomized Trials With Cardiac Magnetic Resonance Imaging Data.

M. Fusaro, G. Ndrepepa, J. Bosson, 2018, The Canadian journal of cardiology.

Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes

A. Kastrati, J. Mehilli, A. Schömig, 2008, European journal of clinical investigation.

Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers.

G. Schmidt, C. Schmitt, A. Schömig, 2001, Journal of the American College of Cardiology.

Proximal occlusion versus distal filter for cerebral protection during carotid stenting: updated meta-analysis of randomised and observational MRI studies.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Everolimus-Eluting Versus Sirolimus-Eluting Stents: A Meta-Analysis of Randomized Trials

A. Kastrati, J. Mehilli, A. Schömig, 2011, Circulation. Cardiovascular interventions.

Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial

H. Schunkert, M. Joner, A. Kastrati, 2022, Journal of the American Heart Association.

Prognostic value of De Ritis ratio in patients with acute myocardial infarction.

A. Kastrati, G. Ndrepepa, S. Holdenrieder, 2022, Clinica chimica acta; international journal of clinical chemistry.

Association of uric acid with mortality in patients with stable coronary artery disease.

M. Hadamitzky, A. Kastrati, A. Schömig, 2012, Metabolism: clinical and experimental.

Prognostic value of uric acid in patients with acute coronary syndromes.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2012, The American journal of cardiology.

Long-Term Outcomes of Patients with Unprotected Left Main Coronary Artery Disease Treated with Percutaneous Angioplasty versus Bypass Grafting: A Meta-Analysis of Randomized Controlled Trials

Gani Bajraktari, M. Henein, G. Ndrepepa, 2020, Journal of clinical medicine.

Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Electrical isolation of pulmonary veins in patients with atrial fibrillation: reduction of fluoroscopy exposure and procedure duration by the use of a non-fluoroscopic navigation system (NavX).

Armin Luik, Claus Schmitt, Isabel Deisenhofer, 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Radiofrequency Ablation of Cardiac Arrhythmias Using a Three‐Dimensional Real‐Time Position Management and Mapping System

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2002, Pacing and clinical electrophysiology : PACE.

Prospective Randomized Comparison of Closed Cooled‐Tip versus 8‐mm‐Tip Catheters for Radiofrequency Ablation of Typical Atrial Flutter

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2002, Journal of cardiovascular electrophysiology.

Uric acid and cardiovascular disease.

G. Ndrepepa, 2018, Clinica chimica acta; international journal of clinical chemistry.

Hypothermia in patients with acute myocardial infarction: a meta-analysis of randomized trials

H. Thiele, M. Joner, A. Kastrati, 2020, Clinical Research in Cardiology.

Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease.

G. Ndrepepa, 2019, Clinica chimica acta; international journal of clinical chemistry.

Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

H. Schunkert, M. Joner, A. Kastrati, 2022, Thrombosis and Haemostasis.

Actions of lidocaine on reentrant ventricular rhythms in the subacute myocardial infarction period in dogs.

G. Ndrepepa, E. Caref, H. Yin, 1997, The American journal of physiology.

Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction.

Adnan Kastrati, Markus Schwaiger, Albert Schömig, 2007, Journal of the American College of Cardiology.

Acute effects and long-term outcome of pulmonary vein isolation in combination with electrogram-guided substrate ablation for persistent atrial fibrillation.

Armin Luik, Claus Schmitt, Isabel Deisenhofer, 2008, The American journal of cardiology.

Ectopic Tachycardia Originating from the Superior Vena Cava

C. Schmitt, G. Ndrepepa, Jun Dong, 2002, Journal of cardiovascular electrophysiology.

Basket Catheter‐Guided Three‐Dimensional Activation Patterns Construction and Ablation of Common Type Atrial Flutter

Michael A. E. Schneider, A. Schomig, C. Schmitt, 2000, Pacing and clinical electrophysiology : PACE.

Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Electrophysiological Differences of the Spontaneous Onset of Paroxysmal and Persistent Atrial Fibrillation

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2007, Pacing and clinical electrophysiology : PACE.

Acute Electrophysiologic Effects and Antifibrillatory Actions of the Long Linear Lesions in the Right Atrium in a Sheep Model

Michael A. E. Schneider, C. Schmitt, A. Schömig, 2000, Journal of Interventional Cardiac Electrophysiology.

Electrophysiologic characteristics of the spontaneous onset and termination of atrial fibrillation.

Claus Schmitt, Michael A. E. Schneider, Albert Schömig, 2002, The American journal of cardiology.

Mapping studies in atrial fibrillation

C. Schmitt, G. Ndrepepa, S. Weber, 2002, Herzschrittmachertherapie und Elektrophysiologie.

Atresia of the Coronary Sinus in Patients with Supraventricular Tachycardia

C. Schmitt, B. Zrenner, G. Ndrepepa, 2006, Pacing and clinical electrophysiology : PACE.

Complex Fractionated Atrial Electrogram or Linear Ablation in Patients with Persistent Atrial Fibrillation—A Prospective Randomized Study

C. Schmitt, B. Zrenner, G. Ndrepepa, 2011, Pacing and clinical electrophysiology : PACE.

Uric acid and prognosis in angiography‐proven coronary artery disease

M. Hadamitzky, A. Kastrati, A. Schömig, 2013, European journal of clinical investigation.

Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation.

Claus Schmitt, Michael A. E. Schneider, Isabel Deisenhofer, 2002, The American journal of cardiology.

Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.

C. Schmitt, A. Schömig, G. Ndrepepa, 2001, European heart journal.

Comparative prognostic value of C-reactive protein & fibrinogen in patients with coronary artery disease

A. Kastrati, G. Ndrepepa, T. Tada, 2014, The Indian journal of medical research.

Pulmonary Vein Internal Electrical Activity Does Not Contribute to the Maintenance of Atrial Fibrillation

Michael A. E. Schneider, C. Schmitt, A. Schömig, 2003, Pacing and clinical electrophysiology : PACE.

Impact of Atrial Fibrillation on the Voltage of Bipolar Signals Acquired from the Left and Right Atria

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2003, Pacing and clinical electrophysiology : PACE.

Psychological distress and mortality in stable coronary heart disease: persistence of high distress means increased risk

G. Ndrepepa, 2017, Heart.

Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial.

S. Nekolla, M. Schwaiger, A. Kastrati, 2005, JAMA.

One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, European heart journal.

Characterization of Paroxysmal and Persistent Atrial Fibrillation in the Human Left Atrium During Initiation and Sustained Episodes

Claus Schmitt, Michael A. E. Schneider, Isabel Deisenhofer, 2002, Journal of cardiovascular electrophysiology.

Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease

Gani Bajraktari, G. Ndrepepa, S. Elezi, 2006, International journal of clinical practice.

Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials

Heribert Schunkert, Adnan Kastrati, Takeshi Kimura, 2016, The Lancet.

Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2004, The American journal of cardiology.

Prediction of risk for bleeding, myocardial infarction and mortality after percutaneous coronary intervention in patients with acute coronary syndromes

H. Schunkert, M. Joner, A. Kastrati, 2022, Coronary artery disease.

Microvascular obstruction in patients with non-ST-elevation myocardial infarction: a contrast-enhanced cardiac magnetic resonance study

M. Hadamitzky, H. Schunkert, A. Kastrati, 2014, The International Journal of Cardiovascular Imaging.

ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention.

A. Kastrati, J. Mehilli, F. Neumann, 2010, European heart journal.

ISAR-REACT 3 A : a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention

A. Kastrati, J. Mehilli, F. Neumann, 2022 .

Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes

H. Schunkert, M. Joner, A. Kastrati, 2021, Journal of the American Heart Association.

CLINICAL RESEARCH Acute Coronary Syndromes Gender and Myocardial Salvage After Reperfusion Treatment in Acute Myocardial Infarction

S. Nekolla, M. Schwaiger, A. Kastrati, 2005 .

Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions

L. Räber, A. Kastrati, S. Windecker, 2018, Circulation. Cardiovascular interventions.

High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention.

Karl-Ludwig Laugwitz, Heribert Schunkert, Ilka Ott, 2016, Journal of the American College of Cardiology.

Percutaneous Coronary Intervention in Acute ST Segment Elevation Myocardial Infarction

A. Kastrati, A. Schömig, G. Ndrepepa, 2012 .

Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.

A. Kastrati, J. Mehilli, F. Neumann, 2008, European heart journal.

Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial.

A. Kastrati, J. Mehilli, F. Neumann, 2010, European heart journal.

Effect of abciximab on clinical and angiographic restenosis in patients with non-ST-segment elevation acute coronary syndromes.

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, The American journal of cardiology.

Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention

A. Kastrati, J. Mehilli, F. Neumann, 2010, Heart and Vessels.

High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2023, Clinical research in cardiology : official journal of the German Cardiac Society.

Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease.

A. Kastrati, A. Schömig, G. Ndrepepa, 2013, The American journal of cardiology.

Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease.

M. Hadamitzky, A. Kastrati, A. Schömig, 2013, Clinical science.

Accuracy of N-terminal pro-brain natriuretic peptide to predict mortality in various subsets of patients with coronary artery disease.

Adnan Kastrati, Albert Schömig, A. Kastrati, 2007, The American journal of cardiology.

A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes

A. Kastrati, J. Mehilli, A. Schömig, 2006, Clinical Research in Cardiology.

Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.

A. Kastrati, J. Mehilli, J. Pache, 2007, American heart journal.

Sex-associated differences in clinical outcomes after coronary stenting in patients with diabetes mellitus.

A. Kastrati, J. Mehilli, J. Pache, 2004, The American journal of medicine.

Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions

A. Kastrati, J. Mehilli, A. Schömig, 2007, Thrombosis and Haemostasis.

Homocysteine Status and Polymorphisms of Methylenetetrahydrofolate Reductase Are Not Associated With Restenosis After Stenting in Coronary Arteries

A. Kastrati, J. Mehilli, A. Schömig, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Patterns of Presentation and Outcomes of Patients with Acute Coronary Syndromes

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, Cardiology.

Association of progression or regression of coronary artery atherosclerosis with long-term prognosis.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, American heart journal.

The quality of arterial hypertension treatment in cardiology service in Kosovo--a single center study.

Gani Bajraktari, G. Ndrepepa, S. Elezi, 2009, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Journal of the American College of Cardiology.

A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2006, Clinica chimica acta; international journal of clinical chemistry.

Improved Activation Time Assignment of Unipolar Electrograms from Ischemic Canine Epicardium

G. Ndrepepa, E. Caref, N. El-Sherif, 2011, Pacing and clinical electrophysiology : PACE.

Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2010, The American journal of cardiology.

Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial.

H. Schunkert, M. Joner, A. Kastrati, 2021, European heart journal. Acute cardiovascular care.

Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation.

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2003, European heart journal.

Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries: A Meta-Analysis of Randomized Trials.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, JACC. Cardiovascular interventions.

Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2013, JACC. Cardiovascular interventions.

Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison.

A. Kastrati, G. Ndrepepa, I. Ott, 2013, International journal of cardiology.

Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2003 .

Relationship between surface electrocardiogram characteristics and endocardial activation sequence in patients with typical atrial flutter

C. Schmitt, B. Zrenner, G. Ndrepepa, 2000, Zeitschrift für Kardiologie.

Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system.

C Schmitt, C. Schmitt, A. Schömig, 2001, The American journal of cardiology.

Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention

A. Kastrati, G. Ndrepepa, S. Cassese, 2014, Journal of Thrombosis and Thrombolysis.

Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy.

H. Schunkert, A. Kastrati, F. Neumann, 2013, American heart journal.

Prognostic Value of Access and Non–Access Sites Bleeding After Percutaneous Coronary Intervention

A. Kastrati, F. Neumann, G. Ndrepepa, 2013, Circulation. Cardiovascular interventions.

Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Association of midregional proadrenomedullin with coronary artery stenoses, soft atherosclerotic plaques and coronary artery calcium

A. Kastrati, J. Hausleiter, A. Schömig, 2012, Heart and Vessels.

Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease

H. Schunkert, A. Kastrati, F. Neumann, 2013, Clinical Research in Cardiology.

Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Heart and Vessels.

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomised trials versus other limus-eluting stents and an adjusted indirect comparison

A. Kastrati, G. Ndrepepa, T. Tada, 2012, Heart.

Everolimus-Eluting Versus Sirolimus-Eluting StentsClinical Perspective

A. Kastrati, J. Mehilli, A. Schömig, 2011 .

Relation of body mass index to bleeding during percutaneous coronary interventions.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2015, The American journal of cardiology.

Aspartate aminotransferase and cardiovascular disease—a narrative review

G. Ndrepepa, 2020 .

De Ritis ratio and long‐term major cardiovascular adverse events in patients undergoing elective percutaneous coronary intervention

A. Kastrati, G. Ndrepepa, S. Holdenrieder, 2022, European journal of clinical investigation.

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus.

H. Schunkert, A. Kastrati, F. Neumann, 2020, JACC. Cardiovascular interventions.

A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease.

A. Kastrati, A. Schömig, G. Ndrepepa, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Predictors of increased left ventricular filling pressure in dialysis patients with preserved left ventricular ejection fraction.

Gani Bajraktari, G. Ndrepepa, Irfan Daullxhiu, 2009, Croatian medical journal.

Radiofrequency Ablation of Complex Fractionated Atrial Electrograms (CFAE): Preferential Sites of Acute Termination and Regularization in Paroxysmal and Persistent Atrial Fibrillation

Armin Luik, Claus Schmitt, Isabel Deisenhofer, 2007, Journal of cardiovascular electrophysiology.

Inappropriate Shock Delivery Due to Ventricular Double Detection with a Biventricular Pacing Implantable Cardioverter Defibrillator

C. Schmitt, B. Zrenner, G. Ndrepepa, 2001, Pacing and clinical electrophysiology : PACE.

C. Schmitt, B. Zrenner, G. Ndrepepa, 2002, Zeitschrift für Kardiologie.

Left Atrial Fibrillation with Regular Right Atrial Activation and a Single Left‐to‐Right Electrical Interatrial Connection:

Michael A. E. Schneider, C. Schmitt, A. Schömig, 2000, Journal of cardiovascular electrophysiology.

Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2008, American heart journal.

Ablation of cardiac arrhythmias — energy sources and mechanisms of lesion formation

Heidi Estner, G. Ndrepepa, Gjin Ndrepepa, 2006 .

Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention.

A. Kastrati, A. Schömig, G. Ndrepepa, 2013, European journal of internal medicine.

Obesity paradox after percutaneous coronary intervention - closing in on the truth behind the phenomenon.

A. Kastrati, G. Ndrepepa, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

High-sensitivity cardiac troponin T and prognosis in patients with ST-segment elevation myocardial infarction.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2018, Journal of cardiology.

Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials

H. Schunkert, M. Joner, A. Kastrati, 2020, Clinical Research in Cardiology.

Prognostic value of glomerular function estimated by Cockcroft-Gault creatinine clearance, MDRD-4, CKD-EPI and European Kidney Function Consortium equations in patients with acute coronary syndromes.

H. Schunkert, M. Joner, A. Kastrati, 2021, Clinica chimica acta; international journal of clinical chemistry.

Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Journal of translational medicine.

Non-insulin dependent diabetes as an independent predictor of asymptomatic left ventricular diastolic dysfunction.

Gani Bajraktari, G. Ndrepepa, S. Elezi, 2005, Croatian medical journal.

P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes.

A. Kastrati, G. Ndrepepa, 2023, European heart journal.

Rehospitalization Events After Aortic Valve Replacement: Insights From the PARTNER Trial

H. Schunkert, M. Joner, A. Kastrati, 2022, Circulation. Cardiovascular interventions.

Long‐term prognostic value of risk scores after drug‐eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR‐LEFT‐MAIN and ISAR‐LEFT‐MAIN 2 randomized clinical trials

H. Schunkert, A. Kastrati, J. Mehilli, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation

H. Schunkert, M. Joner, A. Kastrati, 2022, Circulation. Cardiovascular interventions.

Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age

A. Kastrati, F. Neumann, G. Ndrepepa, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

ECG changes in a 25-year-old woman with hypocalcemia due to hypoparathyroidism. Hypocalcemia mimicking acute myocardial infarction.

C. Schmitt, G. Ndrepepa, I. Deisenhofer, 2000, Chest.

Relation of Gamma-Glutamyl Transferase to Cardiovascular Events in Patients With Acute Coronary Syndromes.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, The American journal of cardiology.

Electrogram-guided substrate ablation with or without pulmonary vein isolation in patients with persistent atrial fibrillation.

Claus Schmitt, Isabel Deisenhofer, Christof Kolb, 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Noncontact Mapping‐Guided Ablation of Atrial Flutter and Enhanced‐Density Mapping of the Inferior Vena Caval‐Tricuspid Annulus Isthmus

Michael A. E. Schneider, C. Schmitt, A. Schömig, 2001, Pacing and clinical electrophysiology : PACE.

Mapping and ablation of atrial arrhythmias after surgical correction of congenital heart disease guided by a 64-electrode basket catheter.

C. Schmitt, A. Schömig, B. Zrenner, 2001, The American journal of cardiology.

LocaLisa Catheter Navigation Reduces Fluoroscopy Time and Dosage in Ablation of Atrial Flutter:

Michael A. E. Schneider, C. Schmitt, A. Schömig, 2003, Journal of cardiovascular electrophysiology.

Three-dimensional electroanatomic mapping systems

G. Ndrepepa, 2006 .

Ticagrelor-based antiplatelet regimens in patients with atherosclerotic artery disease-A meta-analysis of randomized clinical trials.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, American heart journal.

Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes.

A. Kastrati, F. Neumann, J. Pache, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Subintimal Versus Intraplaque Recanalization of Coronary Chronic Total Occlusions: Mid-Term Angiographic and OCT Findings From the ISAR-OCT-CTO Registry.

M. Joner, A. Kastrati, G. Ndrepepa, 2019, JACC. Cardiovascular interventions.

Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Patients With Chronic Stable Angina

A. Kastrati, J. Mehilli, A. Schömig, 2005, Circulation.

Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trial.

A. Wieczorek, A. Kastrati, J. Mehilli, 2007, Journal of the American College of Cardiology.

Efficacy of reperfusion with primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction

A. Kastrati, A. Schömig, G. Ndrepepa, 2011, Clinical Research in Cardiology.

Prognostic value of thyroid-stimulating hormone within reference range in patients with coronary artery disease.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2015, Metabolism: clinical and experimental.

A pan-coronary artery angiographic study of the association between diabetes mellitus and progression or regression of coronary atherosclerosis

H. Schunkert, A. Kastrati, G. Ndrepepa, 2017, Heart and Vessels.

Impact of inhospital stent thrombosis and cerebrovascular accidents on long-term prognosis after percutaneous coronary intervention.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2014, American heart journal.

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate.

H. Schunkert, M. Joner, A. Kastrati, 2021, JACC: Cardiovascular Interventions.

Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin.

Jörg Hausleiter, Karl-Ludwig Laugwitz, Ilka Ott, 2011, American heart journal.

Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A. Kastrati, G. Ndrepepa, S. Kufner, 2015, European journal of clinical investigation.

Correlates of poor outcome among patients with bleeding after coronary interventions

A. Kastrati, G. Ndrepepa, K. Laugwitz, 2014, Coronary artery disease.

Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials

H. Schunkert, M. Joner, A. Kastrati, 2018, European heart journal cardiovascular Imaging.

Internal Atrial Defibrillation During Electrophysiological Studies and Focal Atrial Fibrillation Ablation Procedures

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2001, Pacing and clinical electrophysiology : PACE.

Computer-assisted animation of atrial tachyarrhythmias recorded with a 64-electrode basket catheter.

C. Schmitt, A. Schömig, B. Zrenner, 1999, Journal of the American College of Cardiology.

Anomalies origin of the right coronary artery from the left coronary sinus and coursing between the pulmonary artery and aorta associated with mitral stenosis

G. Ndrepepa, M. Lezha, U. Ekmekçiu, 2015 .

Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range

H. Schunkert, A. Kastrati, G. Ndrepepa, 2023, Journal of clinical medicine.

Prognostic Value of De Ritis Ratio with Aspartate Aminotransferase and Alanine Aminotransferase Within the Reference Range.

A. Kastrati, G. Ndrepepa, S. Holdenrieder, 2022, Clinica chimica acta; international journal of clinical chemistry.

Postprocedural high-sensitivity troponin T and prognosis in patients with non-ST-segment elevation myocardial infarction treated with early percutaneous coronary intervention.

L. Räber, A. Kastrati, S. Windecker, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials.

H. Schunkert, M. Joner, A. Kastrati, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Recent advances in cardiac mapping techniques

Michael A. E. Schneider, C Schmitt, C. Schmitt, 1999, Current cardiology reports.

Elevated serum uric acid: a marker and mediator of increased stress on myocardium.

G. Ndrepepa, 2018, Coronary artery disease.

The Recording of Monophasic Action Potentials with Fractal‐Coated Iridium Electrodes in Humans

Michael A. E. Schneider, A. Schömig, B. Zrenner, 2000, Pacing and clinical electrophysiology : PACE.

Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial.

H. Schunkert, M. Joner, A. Kastrati, 2021, JAMA cardiology.

Late dofetilide-associated life-threatening proarrhythmia.

B. Zrenner, G. Ndrepepa, C. Kolb, 2008, International journal of cardiology.

Noncontact Mapping‐Guided Catheter Ablation of Atrial Fibrillation Associated with Left Atrial Ectopy

Michael A. E. Schneider, C. Schmitt, B. Zrenner, 2000, Journal of cardiovascular electrophysiology.

Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016 .

High-density lipoprotein: a double-edged sword in cardiovascular physiology and pathophysiology

G. Ndrepepa, 2021 .

Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy

A. Kastrati, G. Ndrepepa, 2023, Journal of clinical medicine.

De Ritis ratio and cardiovascular disease: evidence and underlying mechanisms

G. Ndrepepa, 2022, Journal of Laboratory and Precision Medicine.

H. Schunkert, A. Kastrati, J. Mehilli, 2017 .

Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Journal of Translational Medicine.

Stent?: Results of the ISAR-PEACE Randomized Trial Does Addition of Estradiol Improve the Efficacy of a Rapamycin-Eluting

A. Wieczorek, J. Mehilli, A. Schömig, 2007 .

Research update for articles published in EJCI in 2015

N. Goswami, A. Roessler, M. Qorbani, 2017, European journal of clinical investigation.

Cangrelor - a champion lost in translation?

A. Kastrati, G. Ndrepepa, 2009, The New England journal of medicine.

M. Schwaiger, A. Kastrati, J. Mehilli, 2002, Circulation.

Activated clotting time during percutaneous coronary intervention: a test for all seasons or a mind tranquilizer?

A. Kastrati, G. Ndrepepa, 2015, Circulation. Cardiovascular interventions.

Procedural and clinical performance of dual‐ versus single‐catheter strategy for transradial coronary angiography: A meta‐analysis of randomized trials

A. Kastrati, G. Ndrepepa, U. Landmesser, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Microvascular obstruction in patients with non-ST-elevation myocardial infarction: a contrast-enhanced cardiac magnetic resonance study

M. Hadamitzky, H. Schunkert, A. Kastrati, 2014, The International Journal of Cardiovascular Imaging.

BMI and coronary heart disease: no difference according to sex.

G. Ndrepepa, 2015, The lancet. Diabetes & endocrinology.

Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease

Gani Bajraktari, G. Ndrepepa, S. Elezi, 2006, International journal of clinical practice.

Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction.

S. Nekolla, M. Schwaiger, A. Kastrati, 2005, Journal of the American College of Cardiology.

Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin.

A. Kastrati, J. Mehilli, M. Seyfarth, 2011, American heart journal.

Angiographic coronary no-reflow after primary percutaneous coronary intervention - a combination of an insensitive diagnostic method, inappropriate timing and rushed judgement.

G. Ndrepepa, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Sensitive troponin and N‐terminal probrain natriuretic peptide in stable angina

A. Kastrati, J. Mehilli, M. Seyfarth, 2011, European journal of clinical investigation.

Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis

H. Schunkert, M. Joner, A. Kastrati, 2019, Clinical Research in Cardiology.

Aspirin loading and coronary no-reflow after percutaneous coronary intervention in patients with acute myocardial infarction.

G. Ndrepepa, S. Kufner, K. Laugwitz, 2024, European journal of clinical investigation.

Hypocalcemia Mimicking Acute Myocardial Infarction

C. Schmitt, G. Ndrepepa, I. Deisenhofer, 2015 .

Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes.

A. Kastrati, J. Mehilli, M. Seyfarth, 2008, Journal of the American College of Cardiology.

Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta‐Analysis

M. Joner, A. Kastrati, G. Ndrepepa, 2021, Journal of the American Heart Association.

Two‐to‐one Conduction Block Between Left Atrium and Right Lower Pulmonary Vein Preceding Complete Vein Isolation During Radiofrequency Current Ablation

Michael A. E. Schneider, C. Schmitt, G. Ndrepepa, 2004, Pacing and clinical electrophysiology : PACE.

Single Chamber Atrial Fibrillation Involving Only the Left Atrium:

Claus Schmitt, Michael A. E. Schneider, Stefan Weber, 2003, Pacing and clinical electrophysiology : PACE.

Characterization of Onset Mechanism and Waveform Analysis in Patients with Atrial Fibrillation Using a High‐Resolution Noncontact Mapping System

Michael A. E. Schneider, C. Schmitt, A. Schömig, 2003, Journal of cardiovascular electrophysiology.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Body mass index and efﬁcacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes

G. Ndrepepa, D. Angiolillo, D. Sibbing, 2022 .

Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes.

A. Kastrati, J. Mehilli, J. Pache, 2011, Clinica chimica acta; international journal of clinical chemistry.

Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data

Samin K. Sharma, A. Jaffe, S. Ooi, 2021 .